Unique ID issued by UMIN | UMIN000008020 |
---|---|
Receipt number | R000009435 |
Scientific Title | Effects of nutritional support care in patients receiving outpatient chemotherapy to the colorectal area |
Date of disclosure of the study information | 2012/05/23 |
Last modified on | 2014/11/18 19:26:30 |
Effects of nutritional support care in patients receiving outpatient chemotherapy to the colorectal area
Effects of nutritional support care in patients receiving outpatient chemotherapy to the colorectal area
Effects of nutritional support care in patients receiving outpatient chemotherapy to the colorectal area
Effects of nutritional support care in patients receiving outpatient chemotherapy to the colorectal area
Japan |
colorectal cancer
Surgery in general | Gastrointestinal surgery |
Malignancy
NO
To evaluate the nutritional support care effects to the prevention of weight reduction, nutritional status, completion rate of treatment and reduction of adverse events in patients receiving outpatients chemotherapy to the colorectal area.
Efficacy
Exploratory
Not applicable
Body weight reduction rate during the chemotherapy
Hematology and blood chemistry, (Alb, Pre-Alb, total cholesterol, total lymphocyte count, total protein, CRP, Ghrelin)
Occurrence of adverse event
The ratio of the patients who completed the treatment course
ADL (Activities of Daily Living)
Interventional
Single arm
Non-randomized
Open -no one is blinded
No treatment
1
Treatment
Medicine |
To administrate the ethical liquid enteral nutrition formula (Racol NF) 400kcal per day from the day start chemotherapy to the day complete of the study.
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients who will receive chemotherapy to the colorectal area
2. Patients who have histologically diagnosed colorectal carcinoma.
3. Patients aged 20 years and older at the time of informed consent.
4. Patients with ECOG performance status of 0 to 2.
5. Patients who not have severe disorder to heart, lung, bone marrow, liver and kidney.
6. Patients without severe complications.
7. Patients and legal representative have given voluntary written informed consent.
1. Patients with severe narrowing of colon lumen
2. Patients with short-bowel syndrome
3. Patients with severe liver/renal disorder
4. Patients with severe diabetes mellitus (HbA1c >7.0%)
5. Patients with inborn error of amino acid metabolism
6. Patients with allergy to any ingredient of milk.
7. Patients with abnormal electrolyte metabolism
8. Patient s with hemophilia
9. Patients who have received blood transfusion within a month
10. Pregnant women or women
30
1st name | |
Middle name | |
Last name | Kiyotaka Kurachi |
Hamamatsu University School of Medicine
Department of Second Surgery
1-20-1, handayama, higashi-ku, Hamamatu, Shizuoka, 431-3192
053-435-2279
kurachi1@hama-med.ac.jp
1st name | |
Middle name | |
Last name | Kiyotaka Kurachi |
Hamamatsu University School of Medicine
Department of Second Surgery
1-20-1, handayama, higashi-ku, Hamamatu, Shizuoka, 431-3192
053-435-2279
kurachi1@hama-med.ac.jp
Hamamatsu University School of Medicine
none
Self funding
NO
国立大学法人浜松医科大学浜松医科大学医学部附属病院(静岡県)
2012 | Year | 05 | Month | 23 | Day |
Unpublished
No longer recruiting
2012 | Year | 03 | Month | 26 | Day |
2012 | Year | 06 | Month | 01 | Day |
2014 | Year | 12 | Month | 31 | Day |
2012 | Year | 05 | Month | 23 | Day |
2014 | Year | 11 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009435